Cura Therapeutics
Founded Year
2017Stage
Seed | AliveTotal Raised
$100KLast Raised
$100K | 4 yrs agoAbout Cura Therapeutics
Cura Therapeutics operates as a therapeutics company. The company develops immunotherapeutic drugs to cure cancer and infectious diseases. It was founded in 2017 and is based in Saint-Laurent, Canada.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Cura Therapeutics Patents
Cura Therapeutics has filed 8 patents.
The 3 most popular patent topics include:
- Prodrugs
- Pyridines
- Stereochemistry
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/8/2019 | 7/18/2023 | Prodrugs, Pyridines, Stereochemistry, Benzamides, Enantiopure drugs | Grant |
Application Date | 1/8/2019 |
|---|---|
Grant Date | 7/18/2023 |
Title | |
Related Topics | Prodrugs, Pyridines, Stereochemistry, Benzamides, Enantiopure drugs |
Status | Grant |
Cura Therapeutics Frequently Asked Questions (FAQ)
When was Cura Therapeutics founded?
Cura Therapeutics was founded in 2017.
Where is Cura Therapeutics's headquarters?
Cura Therapeutics's headquarters is located at NEOMED INSTITUTE, Saint-Laurent.
What is Cura Therapeutics's latest funding round?
Cura Therapeutics's latest funding round is Seed.
How much did Cura Therapeutics raise?
Cura Therapeutics raised a total of $100K.
Who are the investors of Cura Therapeutics?
Investors of Cura Therapeutics include Berkeley SkyDeck.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
